We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at ...

The company is also entering new markets, such as neuromodulation for treatment-resistant depression, a $1 billion opportunity. Overall, Abbott’s innovation and broad product portfolio position ...

Despite facing a challenging industry-wide investment climate driven by tariffs, Abbott ABT has managed to achieve an 18.8% ...

Medtronic is expected to report strong growth within the Neuromodulation segment, driven by its closed-loop sensing technology for both Pain Stim and Brain Modulation. Pelvic Health, Coronary and ...

Despite a turbulent tariff terrain in 2025, Abbott has sprinted ahead with an 18.8% gain, trouncing both peers and benchmarks ...

With his signature voucher legislation signed into law, Gov. Greg Abbott is going all in on a massive bail crackdown as the legislative session enters the final stretch. The Texas Republican ...

In its first-quarter 2025 investor letter, Mairs & Power Balanced Fund highlighted stocks such as Abbott Laboratories (NYSE:ABT). Abbott Laboratories (NYSE:ABT) is a leading manufacturer of health ...